Single versus sequential high-dose chemotherapy (HOCT) in patients with relapsed or refractory germ-cell tumors (GCT).

被引:0
|
作者
Lorch, A.
Rick, O.
Hartmann, J. T.
Kollmannsberger, C.
Metzner, B.
Schmidt-Wolf, I.
Berdel, W. E.
Schirren, R.
Beyer, J.
Bokemeyer, C.
机构
[1] Univ Hosp, Marburg, Germany
[2] Klin Reinhardshoehe, Bad Wildungen, Germany
[3] Univ Hosp, Tubingen, Germany
[4] BC Canc Agcy, Vancouver, BC, Canada
[5] Staedt Kliniken, Oldenburg, Germany
[6] Univ Hosp Bonn, Bonn, Germany
[7] Univ Hosp, Munster, Germany
[8] Oberschwabenklin, Ravensburg, Germany
[9] Univ Hosp, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:219S / 219S
页数:1
相关论文
共 50 条
  • [21] Management of progressive brain metastases in patients (pts) with relapsed germ-cell tumor (GCT) treated with salvage high-dose chemotherapy (HDCT).
    King, Jennifer
    Abonour, Rafat
    Hassoun, Rebecca
    Althouse, Sandra K.
    Salous, Tareq
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
    Beyer, J.
    Hackenthal, M.
    Lorch, A.
    Neubauer, A.
    Dieing, A.
    Rick, O.
    Hartmann, J. T.
    Bokemeyer, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Salvage high-dose chemotherapy in female patients with relapsed/refractory germ cell tumors: The EBMT experience.
    De Giorgi, Ugo
    Richard, Sandrine
    Badoglio, Manuela
    Kanfer, Edward
    Bourrhis, Jean Henri
    Nicolas-Virelizier, Emmanuelle
    Liouret, Bruno
    Vettenranta, Kim
    Martin, Sonja
    Dreger, Peter
    Schuler, Markus Kajo
    Scarpi, Emanuela
    Rosti, Giovanni
    Selle, Frederic
    Lanza, Francesco
    Bregni, Marco
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Salvage high-dose chemotherapy (HDCT) for relapsed primary mediastinal nonseminomatous germ-cell tumors (PMNSGCT).
    Taza, Fadi
    Abonour, Rafat
    Althouse, Sandra K.
    Ashkar, Ryan
    Abu Zaid, Mohammad Issam
    Hanna, Nasser H.
    Kessler, Kenneth A.
    Adra, Nabil
    Einhorn, Lawrence H.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [25] Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)
    Taza, Fadi
    Abonour, Rafat
    Zaid, Mohammad Abu
    Althouse, Sandra K.
    Anouti, Bilal
    Akel, Reem
    Hanna, Nasser H.
    Adra, Nabil
    Einhorn, Lawrence H.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (02) : 213 - 220
  • [26] HIGH-DOSE CARBOPLATIN AND ETOPOSIDE FOR SALVAGE CHEMOTHERAPY OF GERM-CELL TUMORS
    LAMPE, H
    DEARNALEY, DP
    PRICE, A
    MEHTA, J
    POWLES, R
    NICHOLLS, J
    HORWICH, A
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 717 - 723
  • [27] High-dose chemotherapy in poor-risk germ-cell tumors
    Nichols, CR
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 1427 - 1427
  • [28] Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
    De Giorgi, U.
    Richard, S.
    Badoglio, M.
    Kanfer, E.
    Bourrhis, J. H.
    Nicolas-Virelizier, E.
    Vettenranta, K.
    Lioure, B.
    Martin, S.
    Dreger, P.
    Schuler, M. K.
    Thomson, K.
    Scarpi, E.
    Rosti, G.
    Selle, F.
    Mangili, G.
    Lanza, F.
    Bregni, M.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1910 - 1916
  • [29] LONG-TERM OUTCOME OF PATIENTS WITH RELAPSED AND REFRACTORY GERM-CELL TUMORS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE
    BROUN, ER
    NICHOLS, CR
    KNEEBONE, P
    WILLIAMS, SD
    LOEHRER, PJ
    EINHORN, LH
    TRICOT, GJK
    ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) : 124 - 128
  • [30] HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANT FOR REFRACTORY GERM-CELL TUMORS
    GUIMARAES, A
    CAMBA, L
    HALL, G
    WARD, H
    THOMSON, G
    BOLAM, S
    NEWLANDS, E
    SAMSON, D
    RUSTIN, G
    MCCARTHY, D
    LEUKEMIA & LYMPHOMA, 1992, 7 : 65 - 68